Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...
Zacks Investment Research on MSN
Will CRMD's bearish 2026 view impact DefenCath's long-term adoption?
CorMedix CRMD has been riding on the success of its lead product, DefenCath (taurolidine plus heparin), which was approved by ...
It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results